龍頭股份(600630.SH)擬捐贈不超5000萬元的公司產品
格隆匯2月16日丨龍頭股份(600630.SH)公佈,近日來,新型冠狀病毒肺炎疫情牽動着全國人民的心,公司作為一家“老字號”國有品牌企業,秉承“愛國·第一,時尚·健康”的發展理念,為切實履行上市公司社會責任,積極回饋社會,為抗擊疫情貢獻一份力量。公司於2020年2月15日召開第十屆董事會第五次會議審議通過了《關於對外捐贈支持抗擊新型冠狀病毒肺炎疫情的議案》,擬通過上海慈善基金會,向戰鬥在湖北省疫情防控一線的相關單位和工作者,定向捐贈價值不超過5000萬元的公司產品(貼身衣物等公司產品),用於支持抗擊新型冠狀病毒感染肺炎疫情中生活物資的需要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.